ColumnsMental Health Care Providers Dealing With Coronavirus Disease 2019 (COVID-19): What Is the Definition of a Case, How Is That Changing, and What Kinds of Tests Are Available?PRESKORN, SHELDON H. MDAuthor Information PRESKORN: The University of Kansas School of Medicine-Wichita, Wichita, KS Over his 40-year career, S.H.P. has worked with over 140 pharmaceutical and biotech companies in the United States and throughout the world. Over the past year, he has received grants/research support from or has served as a consultant, on the advisory board, or on the speaker’s bureau for Alkermes, BioXcel, Eisai, Janssen, National Institute of Mental Health, Sunovion, and Usona Institute. All clinical trial and study contracts were with and payments made to the University of Kansas Medical Center Research Institute, a research institute affiliated with University of Kansas School of Medicine-Wichita. Please send correspondence to: Sheldon H. Preskorn, MD, University of Kansas School of Medicine-Wichita, 1010 N. Kansas, Wichita, KS 67217. Journal of Psychiatric Practice: May 2020 - Volume 26 - Issue 3 - p 215-218 doi: 10.1097/PRA.0000000000000473 Buy Metrics Abstract The goal of this column is to inform mental health care professionals about the evolving way the diagnosis of Coronavirus Disease 2019 (COVID-19) is being made, with emphasis on tests to assist in making the diagnosis and to determine the presence of antibodies to the virus. This column also provides some general information about the disease, its relative risks, and efforts to develop effective treatments. Links to credible websites that are being continuously updated are also provided for readers who want more information and to stay current with ongoing developments. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.